Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.

Autor:	Shaw JLV; Division of Biochemistry, Eastern Ontario Regional Laboratory Association and The Ottawa Hospital, and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada., Bannuru RR; American Diabetes Association, Arlington, VA., Beach L; Division of Biochemistry, IWK Health, Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada., ElSayed NA; American Diabetes Association, Arlington, VA.; Harvard Medical School, Cambridge, MA., Freckmann G; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany., Füzéry AK; Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada., Fung AWS; Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Providence Health Care and University of British Columbia, Vancouver, British Columbia, Canada., Gilbert J; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Huang Y; Division of Biochemistry, Kingston Health Sciences Centre, and Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Korpi-Steiner N; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Logan S; Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Longo R; Lahey Hospital & Medical Center, Burlington, MA., MacKay D; Departments of Food and Human Nutritional Sciences and Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Maks L; Providence Health Care, Vancouver, British Columbia, Canada., Pleus S; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany., Rogers K; Division of Hospital Medicine, Department of Internal Medicine, The University of New Mexico School of Medicine, Albuquerque, NM., Seley JJ; Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY., Taxin Z; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Thompson-Hutchison F; Integrated Community Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Tolan NV; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Tran NK; Department of Pathology and Laboratory Medicine, UC Davis Health, University of California, Davis, Sacramento, CA., Umpierrez GE; Division of Endocrinology and Metabolism, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA., Venner AA; Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Jazyk:	angličtina
Zdroj:	Diabetes care [Diabetes Care] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
DOI:	10.2337/dci24-0073
Abstrakt:	Continuous glucose monitoring (CGM) systems provide frequent glucose measurements in interstitial fluid and have been used widely in ambulatory settings for diabetes management. During the coronavirus disease 2019 (COVID-19) pandemic, regulators in the U.S. and Canada temporarily allowed for CGM systems to be used in hospitals with the aim of reducing health care professional COVID-19 exposure and limiting use of personal protective equipment. As such, studies on hospital CGM system use have been possible. With improved sensor accuracy, there is increased interest in CGM usage for diabetes management in hospitals. Laboratorians and health care professionals must determine how to integrate CGM usage into practice. The aim of this consensus guidance document is to provide an update on the application of CGM systems in hospital, with insights and opinions from laboratory medicine, endocrinology, and nursing. (© 2024 by the American Diabetes Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu